InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,347.61
(
0.16%
)

Replies to post #221556 on Biotech Values

Replies to #221556 on Biotech Values

DewDiligence

10/22/18 4:00 PM

#221557 RE: dangerM #221556

NKTR—...the awareness that anyone can work on a biased IL2 agonist...

It doesn't help that Howard Robin has set expectations so high by referring to NKTR-214 as the "cornerstone of modern immuno-oncology."